Good morning :)
Place Order
Add to Watchlist

Saroja Pharma Industries India Ltd

SAROJA

Saroja Pharma Industries India Ltd

SAROJA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹20 cr, stock is ranked 4,108
High RiskStock is 5.01x as volatile as Nifty
53.003.64% (-2.00)
53.003.64% (-2.00)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹20 cr, stock is ranked 4,108
High RiskStock is 5.01x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹20 cr, stock is ranked 4,108
High RiskStock is 5.01x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
1.40
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.906.610.52%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Saroja Pharma Industries India is actively involved in trading pharmaceutical active pharmaceutical ingredients (API), pharma intermediates, and chemicals used in human and veterinary medicines, including specialty chemical imports and exports.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Loading...

Financial YearFY 2021FY 2022FY 2023FY 2024TTM
Total Revenue36.7555.9550.3540.86
Raw Materialssubtract33.7350.1348.7032.17
Power & Fuel Costsubtract0.000.010.030.03
Employee Costsubtract0.550.730.830.92
Selling & Administrative Expensessubtract1.442.391.151.27
Operating & Other expensessubtract-0.360.27-3.233.72
Depreciation/Amortizationsubtract0.020.050.070.09
Interest & Other Itemssubtract0.330.801.321.45
Taxes & Other Itemssubtract0.300.440.430.33
EPS740.0095.836.642.53
DPS0.000.000.000.00
Payout ratio0.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Saroja Pharma Industries India Ltd23.301.40
Sun Pharmaceutical Industries Ltd45.106.440.75%
Cipla Ltd29.414.520.87%
Torrent Pharmaceuticals Ltd68.5016.550.84%

Price Comparison

Compare SAROJA with any stock or ETF
Compare SAROJA with any stock or ETF
SAROJA
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

No institutional holdings trend are available

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding73.02%0.00%0.00%0.00%26.98%

Sep 2023

Mar 2024

Shareholding History

SepMar0.00%0.00%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

SAROJA has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Corporate
Saroja Pharma Industries India schedules board meeting

Saroja Pharma Industries India will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
Saroja Pharma Industries India schedules AGM

Saroja Pharma Industries India announced that the 6th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

2 months agoCapital Market - Live